Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Drug design is both a time consuming and expensive endeavour. Computational strategies offer viable options to address this task; deep learning approaches in particular are indeed gaining traction for their capability of dealing with chemical structures. A straightforward way to represent such structures is via their molecular graph, which in turn can be naturally processed by graph neural networks. This paper introduces AMCG, a dual atomic-molecular, conditional, latent-space, generative model built around graph processing layers able to support both unconditional and conditional molecular graph generation. Among other features, AMCG is a one-shot model allowing for fast sampling, explicit atomic type histogram assignation and property optimization via gradient ascent. The model was trained on the Quantum Machines 9 (QM9) and ZINC datasets, achieving state-of-the-art performances. Together with classic benchmarks, AMCG was also tested by generating large-scale sampled sets, showing robustness in terms of sustainable throughput of valid, novel and unique molecules.